Sort
53,477 grants matching “addiction”
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$901,841James L. Sorensen · University Of California, San Francisco · UG1 · FY2017 · DA
A staged, comprehensive investigation for developing insular deep brain stimulation to treat refractory chronic pain
$901,805William Jeffrey Elias · University Of Virginia · UH3 · FY2025 · NS
Small molecule modulators of RXFP3 for alcohol use disorder
$901,666Chunyang Jin · Research Triangle Institute · R01 · FY2025 · AA
Live-cell Activity Architecture in Cancer
$900,601Jin Zhang · University Of California, San Diego · R35 · FY2024 · CA
(Epi)genetic Risk Architectures in Opioid Dependent Brain
$900,490Peter Christopher Scacheri · Case Western Reserve University · R01 · FY2019 · DA
PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT
$900,463Reese Jones · University Of California, San Francisco · N01 · FY2009 · DA
GENETICS OF OPIOID DEPENDENCE
$900,322Yale University · R01 · FY2002 · DA
26- & 39-Week Toxicity Studies of ANS-6637 in Rats and Monkeys (respectively) to Enable 6+ Months Dosing in Alcohol (and other Substance) Use Disorder Phase 3 Studies
$900,000Ivan Diamond · Amygdala Neurosciences, Inc. · U01 · FY2019 · AA
Targeting undruggable RAS for cancer treatment
$899,999Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2022 · CA
Creation of hyperactive transposons for mutagenesis in rodents
$899,865Eric M Ostertag · Transposagen Biopharmaceuticals, Inc. · R44 · FY2011 · RR
Genomic Resource Grant for PhenX Toolkit - expansion and sustainability: Resource Project
$899,773Carol M Hamilton · Research Triangle Institute · U41 · FY2018 · HG
Strengthening Research Collaborations in Health Disparities
$899,689Earl G Yarbrough · Savannah State University · P20 · FY2009 · MD
Supplement to Prevention Research Center: Parenting Among Women Who Are Opioid Users, Project 2
$899,663Leslie Diane Leve · University Of Oregon · P50 · FY2019 · DA
IGF::OT::IGF MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE; POP 8/29/2014 - 7/9/2015; FY14 N01DA-14-8917
$899,400Patrick Beardsley · Virginia Commonwealth University · N01 · FY2014 · DA
IGF::OT::IGF MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE; POP 8/29/2014 - 7/9/2015; FY14 N01DA-14-8917
$899,400Patrick Beardsley · Virginia Commonwealth University · N01 · FY2015 · DA
Clinical Trial Network: Southwest Node
$899,295Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2008 · DA
Clinical Trial Network: Southwest Node
$898,609Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2007 · DA
Retinoid Metabolism and Alcohol Induced Disease
$898,508William S Blaner · Columbia University Health Sciences · RC2 · FY2010 · AA
Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis
$898,025Siddappa N Byrareddy · University Of Nebraska Medical Center · R01 · FY2025 · DA
MOR/DOR Heterodimer Antagonists: A Novel Treatment for Opioid Dependence
$898,009Michael M Morgan · Washington State University · UG3 · FY2020 · DA
Feasibility of a mobile parent-based intervention to reduce alcohol use by highschool seniors
$897,472Michael Hecht · Real Prevention, Llc · R44 · FY2019 · AA
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$896,804Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2010 · DA
Broader Evaluation of TMD Treatment Efficacy and Response (BETTER TMD)
$896,543Jianfu Chen · University Of Southern California · U01 · FY2025 · DE
Evaluation Of Treatments Of Opioid And Cocaine Dependence
$896,466Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2015 · DA
Prevention of Relapse in Addiction
$896,466Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2015 · DA